Massachusetts COVID-19 Vaccine Program (MCVP) Overview

The Massachusetts Department of Public Health (DPH) Immunization Division is working with the Centers for Disease Control (CDC) to distribute the COVID-19 vaccine.

The information on this page will assist you in your vaccination efforts throughout the pandemic. Below are updates and resources for the Massachusetts COVID-19 Vaccine Program (MCVP).

Table of Contents

Who can administer the COVID-19 vaccine?

This COVID-19 Vaccinators chart (updated October 26, 2021) lists the different groups of individuals who can administer COVID-19 vaccines.

COVID-19 vaccine provider training and resources

Eligibility to receive COVID-19 vaccine supply

All providers participating in the Massachusetts COVID-19 Vaccine Program (MCVP) are required to sign an MCVP Agreement to receive delivery of any COVID-19 vaccine.

  • Providers must be registered with the Massachusetts Immunization Information System (MIIS), in order to submit immunization administration data.
  • Providers registered with the MIIS all received the MCVP Agreement. New sites that register with the MIIS will receive the Agreement automatically. If you have not received the Agreement, contact the DPH Vaccine Unit at dph-vaccine-management@mass.gov. The MCVP Agreement must be completed in order to receive vaccine.
  • Providers must complete the onboarding process with the MIIS User Support Team to ensure that immunization data are being sent to the MIIS registry.

Additional resources:

COVID-19 vaccine storage & handling

Routine vaccination during the COVID-19 Pandemic

Routine vaccination is essential to protecting our communities against vaccine preventable diseases. CDC and DPH recommend that routine vaccinations are maintained throughout the COVID-19 pandemic.

  • CDC recommends that provider offices identify children due for vaccination and schedule appointments starting with newborns and children up to 24 months, young children, and adolescents.
  • COVID-19 vaccines may be administered without regard to timing of other vaccines. For more information on coadministration of COVID-19 vaccines with other vaccines visit    Timing, Spacing and Interchangeability of COVID-19 Vaccines
  • For more information on immunization services during the COVID-19 Pandemic visit www.cdc.gov/vaccines/pandemic-guidance

US COVID-19 Vaccine Products

COVID-19 vaccination is recommended for everyone ages 6 months and older in the United States for the prevention of COVID-19.

Four COVID-19 vaccines are currently approved under a Biologics License Application (BLA) or authorized under an Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA):

Feedback